• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组蛋白去乙酰化酶 2 的过表达通过调节细胞凋亡和细胞周期蛋白的表达赋予人肺癌细胞致癌潜能。

HDAC2 overexpression confers oncogenic potential to human lung cancer cells by deregulating expression of apoptosis and cell cycle proteins.

机构信息

Department of Pathology, College of Medicine and Functional RNomics Research Center, The Catholic University of Korea, Banpo-dong, Seocho-gu, Seoul, Korea.

出版信息

J Cell Biochem. 2012 Jun;113(6):2167-77. doi: 10.1002/jcb.24090.

DOI:10.1002/jcb.24090
PMID:22492270
Abstract

Histone deacetylase 2 (HDAC2) is crucial for embryonic development, affects cytokine signaling relevant for immune responses, and is often significantly overexpressed in solid tumors, but little is known of its role in human lung cancer. In this study, we demonstrated the aberrant expression of HDAC2 in lung cancer tissues and investigated oncogenic properties of HDAC2 in human lung cancer cell lines. HDAC2 inactivation resulted in regression of tumor cell growth and activation of cellular apoptosis via p53 and Bax activation and Bcl2 suppression. In cell cycle regulation, HDAC2 inactivation caused induction of p21WAF1/CIP1 expression, and simultaneously suppressed the expressions of cyclin E2, cyclin D1, and CDK2, respectively. Consequently, this led to the hypophosphorylation of pRb protein in G1/S transition and thereby inactivated E2F/DP1 target gene transcriptions of A549 cells. In addition, we demonstrated that HDAC2 directly regulated p21WAF1/CIP1 expression in a p53-independent manner. However, HDAC1 was not related to p21WAF1/CIP1 expression and tumorigenesis of lung cancer. Lastly, we observed that sustained-suppression of HDAC2 in A549 lung cancer cells attenuated in vitro tumorigenic properties and in vivo tumor growth of the mouse xenograft model. Taken together, we suggest that the aberrant regulation of HDAC2 and its epigenetic regulation of gene transcription in apoptosis and cell cycle components play an important role in the development of lung cancer.

摘要

组蛋白去乙酰化酶 2(HDAC2)对于胚胎发育至关重要,影响与免疫反应相关的细胞因子信号,并且在实体瘤中通常过度表达,但人们对其在人类肺癌中的作用知之甚少。在这项研究中,我们证明了 HDAC2 在肺癌组织中的异常表达,并研究了 HDAC2 在人类肺癌细胞系中的致癌特性。HDAC2 的失活导致肿瘤细胞生长的消退和通过 p53 和 Bax 激活以及 Bcl2 抑制的细胞凋亡的激活。在细胞周期调控中,HDAC2 的失活导致 p21WAF1/CIP1 的表达诱导,同时分别抑制细胞周期蛋白 E2、细胞周期蛋白 D1 和 CDK2 的表达。因此,这导致 pRb 蛋白在 G1/S 转换中的低磷酸化,从而使 A549 细胞中的 E2F/DP1 靶基因转录失活。此外,我们证明 HDAC2 以 p53 非依赖性方式直接调节 p21WAF1/CIP1 的表达。然而,HDAC1 与 p21WAF1/CIP1 的表达和肺癌的肿瘤发生无关。最后,我们观察到 A549 肺癌细胞中 HDAC2 的持续抑制减弱了小鼠异种移植模型中的体外致瘤特性和体内肿瘤生长。总之,我们认为 HDAC2 的异常调节及其在凋亡和细胞周期成分中的基因转录的表观遗传调控在肺癌的发展中起着重要作用。

相似文献

1
HDAC2 overexpression confers oncogenic potential to human lung cancer cells by deregulating expression of apoptosis and cell cycle proteins.组蛋白去乙酰化酶 2 的过表达通过调节细胞凋亡和细胞周期蛋白的表达赋予人肺癌细胞致癌潜能。
J Cell Biochem. 2012 Jun;113(6):2167-77. doi: 10.1002/jcb.24090.
2
Aberrant regulation of HDAC2 mediates proliferation of hepatocellular carcinoma cells by deregulating expression of G1/S cell cycle proteins.组蛋白去乙酰化酶 2 的异常调节通过调节 G1/S 细胞周期蛋白的表达来介导肝癌细胞的增殖。
PLoS One. 2011;6(11):e28103. doi: 10.1371/journal.pone.0028103. Epub 2011 Nov 23.
3
Protein kinase C epsilon is overexpressed in primary human non-small cell lung cancers and functionally required for proliferation of non-small cell lung cancer cells in a p21/Cip1-dependent manner.蛋白激酶Cε在原发性人类非小细胞肺癌中过表达,并且以p21/Cip1依赖的方式在非小细胞肺癌细胞增殖中发挥功能作用。
Cancer Res. 2007 Jul 1;67(13):6053-63. doi: 10.1158/0008-5472.CAN-06-4037.
4
LYG-202 inhibits the proliferation of human colorectal carcinoma HCT-116 cells through induction of G1/S cell cycle arrest and apoptosis via p53 and p21(WAF1/Cip1) expression.LYG-202 通过诱导 p53 和 p21(WAF1/Cip1) 的表达,抑制人结直肠癌细胞 HCT-116 的增殖,导致 G1/S 细胞周期阻滞和细胞凋亡。
Biochem Cell Biol. 2011 Jun;89(3):287-98. doi: 10.1139/o10-162. Epub 2011 Apr 14.
5
Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis.Notch1信号通路通过诱导细胞周期停滞和凋亡来抑制人肝细胞癌的生长。
Cancer Res. 2003 Dec 1;63(23):8323-9.
6
Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.吲哚 - 3 - 甲醇(I3C)可诱导前列腺癌细胞的细胞生长抑制、G1期细胞周期阻滞及凋亡。
Oncogene. 2001 May 24;20(23):2927-36. doi: 10.1038/sj.onc.1204365.
7
Functional interplay between p53 and E2F through co-activator p300.通过共激活因子p300实现p53与E2F之间的功能相互作用。
Oncogene. 1998 May 28;16(21):2695-710. doi: 10.1038/sj.onc.1201818.
8
Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression.细胞周期蛋白D1的调控异位表达可诱导细胞周期蛋白依赖性激酶抑制剂p21基因的转录激活,而不改变细胞周期进程。
Oncogene. 1997 May 29;14(21):2533-42. doi: 10.1038/sj.onc.1201080.
9
Involvement of p21WAF1/CIP1, pRB, Bax and NF-kappaB in induction of growth arrest and apoptosis by resveratrol in human lung carcinoma A549 cells.p21WAF1/CIP1、pRB、Bax和核因子κB在白藜芦醇诱导人肺癌A549细胞生长停滞和凋亡中的作用
Int J Oncol. 2003 Oct;23(4):1143-9.
10
Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.细胞周期蛋白D1、E及细胞周期蛋白依赖性激酶抑制剂p21waf1/cip1、p27kip1在结直肠癌中的表达模式:与其他细胞周期调节因子(pRb、p53、Ki-67及PCNA)及临床病理特征的相关性
Int J Clin Pract. 2008 Nov;62(11):1736-43. doi: 10.1111/j.1742-1241.2006.01105.x.

引用本文的文献

1
Epigenetic Dysregulation in Cancer: Implications for Gene Expression and DNA Repair-Associated Pathways.癌症中的表观遗传失调:对基因表达和DNA修复相关通路的影响。
Int J Mol Sci. 2025 Jul 7;26(13):6531. doi: 10.3390/ijms26136531.
2
Identification of 3-[(4-Acetylphenyl)(4-Phenylthiazol-2-Yl)Amino]Propanoic Acid Derivatives as Promising Scaffolds for the Development of Novel Anticancer Candidates Targeting SIRT2 and EGFR.鉴定3-[(4-乙酰基苯基)(4-苯基噻唑-2-基)氨基]丙酸衍生物作为开发靶向SIRT2和EGFR的新型抗癌候选药物的有前景的骨架。
Pharmaceuticals (Basel). 2025 May 16;18(5):733. doi: 10.3390/ph18050733.
3
Mechanisms of HDACs in cancer development.
组蛋白去乙酰化酶在癌症发展中的作用机制。
Front Immunol. 2025 Apr 7;16:1529239. doi: 10.3389/fimmu.2025.1529239. eCollection 2025.
4
Recent Advancements in the Development of HDAC/Tubulin Dual-Targeting Inhibitors.组蛋白去乙酰化酶/微管蛋白双靶点抑制剂开发的最新进展
Pharmaceuticals (Basel). 2025 Feb 27;18(3):341. doi: 10.3390/ph18030341.
5
The role of histone post-translational modifications in cancer and cancer immunity: functions, mechanisms and therapeutic implications.组蛋白翻译后修饰在癌症及癌症免疫中的作用:功能、机制及治疗意义
Front Immunol. 2024 Nov 15;15:1495221. doi: 10.3389/fimmu.2024.1495221. eCollection 2024.
6
Deciphering the potential role of post-translational modifications of histones in gastrointestinal cancers: a proteomics-based review with therapeutic challenges and opportunities.解读组蛋白翻译后修饰在胃肠道癌症中的潜在作用:基于蛋白质组学的综述及治疗挑战与机遇
Front Oncol. 2024 Oct 21;14:1481426. doi: 10.3389/fonc.2024.1481426. eCollection 2024.
7
Potential role of short-chain fatty acids in the pathogenesis and management of acute lymphocytic leukemia.短链脂肪酸在急性淋巴细胞白血病发病机制及治疗中的潜在作用
Ann Transl Med. 2024 Aug 1;12(4):74. doi: 10.21037/atm-23-1806. Epub 2023 Nov 30.
8
DNA methylation biomarkers distinguishing early-stage prostate cancer from benign prostatic hyperplasia.区分早期前列腺癌与良性前列腺增生的DNA甲基化生物标志物。
Prostate Int. 2023 Jun;11(2):113-121. doi: 10.1016/j.prnil.2023.01.001. Epub 2023 Jan 5.
9
Histone Deacetylase Inhibition and Autophagy Modulation Induces a Synergistic Antiproliferative Effect and Cell Death in Cholangiocarcinoma Cells.组蛋白去乙酰化酶抑制与自噬调节在胆管癌细胞中诱导协同抗增殖作用和细胞死亡。
ACS Omega. 2023 Jun 8;8(24):21755-21768. doi: 10.1021/acsomega.3c01317. eCollection 2023 Jun 20.
10
HDAC2 as a target for developing anti-cancer drugs.组蛋白去乙酰化酶2作为开发抗癌药物的靶点。
Comput Struct Biotechnol J. 2023 Mar 13;21:2048-2057. doi: 10.1016/j.csbj.2023.03.016. eCollection 2023.